Home Start
Lecture
Presentation
Download
Podcast
Enter
Learning Assessment
& Evaluation
Download
Slides
Participar en español

OVERVIEW
This free CE activity consists of a presentation, a learning assessment, and an evaluation. This virtual lecture is derived from a live telephone/web education program presented on December 19, 2011.

MEDIUM: Virtual Lecture
INTERNET RELEASE DATE: February 29, 2012
CME credit is no longer available for this activity.

Estimated time to complete this activity: 1.5 hours


TARGET AUDIENCE
This activity has been designed to meet the educational needs of oncology nurses and social workers involved in the treatment of myeloma.


PROGRAM GOAL
To educate oncology nurses and social workers about emerging therapies in myeloma


EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to:

  • List goals of myeloma treatment
  • Identify current treatment approaches and new developments in myeloma therapies
  • Describe new developments in stem cell transplantation to treat myeloma
  • Describe maintenance therapy updates for myeloma
  • Explain quality of life issues in the treatment of patients with myeloma

FACULTY
ROBERT Z. ORLOWSKI, MD, PhD
Chair, Southwest Oncology Group Myeloma Committee
Professor, Departments of Lymphoma/Myeloma
and Experimental Therapeutics
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, Texas




METHOD OF PARTICIPATION
To complete this activity and receive a statement of credit, participants must:

  1. Review all contents of this activity
  2. Complete and submit the learning assessment and evaluation form
  3. Score at least 70% on the learning assessment

CONTINUING EDUCATION INFORMATION FOR NURSES AND SOCIAL WORKERS
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under provider number CEP 5832 to award 1.5 continuing education contact hours through the California Board of Registered Nursing.

The Leukemia & Lymphoma Society (LLS), provider number 1105, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org Approval Period: December 2011 – December 2014. LLS maintains responsibility for the program. Social workers should contact their regulatory board to determine course approval. Social workers will receive 1.5 CE clinical clock hours.

Upon successful completion of the entire program, post-test (grade of 70% or higher) and submission of the activity evaluation, a certificate of completion will be issued to you within 30 days, via email or US mail based on your designation on the evaluation.


SUPPORT STATEMENT
This program is supported by grants from Celgene Corporation, Millennium Pharmaceuticals, Inc., and Onyx Pharmaceuticals, Inc.


FEE INFORMATION
There is no fee for this educational activity.


QUESTIONS AND TECHNICAL ASSISTANCE
For questions regarding the content of this activity, please contact an LLS Information Specialist at
800-955-4572, or infocenter@lls.org. For technical assistance, contact jungsen@rmcom.net.


SYSTEM REQUIREMENTS
Hardware/Software requirements include:
• Windows 95, 98se, ME, XP, NT 4.0, 2000   
  - Internet Explorer 4.0+
  - Netscape Navigator 6.2+
  - Mozilla Firefox 1.0+

• Macintosh 9.2, OS X 10.1+
  - Safari 1.1+
  - Netscape Navigator 6.2+
  - Internet Explorer 5.2+
  - Mozilla Firefox 1.0+

• Additional Requirements
  - Windows Media Player
  - Internal/external speakers
  - Broadband connection (DSL/cable) recommended

 

 

RMEI Privacy Statement

For questions, grievances, assistance for people with disabilities or more information on LLS programs, please call an LLS Information Specialist at (800) 955-4572.